Observe Carefully (1)pentobarbital will decrease the extent or influence of buprenorphine subdermal implant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. Watch individuals already on buprenorphine subdermal implant who need freshly-initiated treatment method with CYP3A4 inducer for indicators and symptoms